is semaglutide fda approved for weight loss Approves Oral as the First Oral GLP-1 Pill Wegovy pill for weight loss

Older people or those with intestinal malabsorption may also face vitamin B12 deficiency

While older consumers seek tailored formulations, younger generations also want to live healthier, for longer

On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list, finding no clinical need for large-scale compounding of these medications from bulk substances

(4) As a result, the FDA approved Wegovy prescriptions to reduce heart attack risk in addition to its initial weight loss purpose

15% Incidence is an Expected Pattern Dizziness is one of the most common side effects of semaglutide, though its usually mild and temporary